Novo Nordisk 6 may 2026 French regulator fines Novo, Lilly over obesity drug promotion - Fierce Pharma
Novo Nordisk 6 may 2026 Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price - statnews.com
Novo Nordisk 6 may 2026 ‘No change’ for CagriSema as Novo ditches single-chamber device - Fierce Biotech
Novo Nordisk 5 may 2026 Novo Nordisk, Eli Lilly Penalised in France for Indirect Promotion of Obesity Drugs - Medical Dialogues
Novo Nordisk 5 may 2026 Analysts predict Novo Nordisk adjustment after strong Wegovy launch - medwatch.com
Novo Nordisk 4 may 2026 Novo Nordisk Rebrands Rybelsus as Ozempic Pills to Strengthen US Position - Medical Dialogues
Novo Nordisk 4 may 2026 Novo Nordisk relaunches diabetes pill in the US under Ozempic brand - medwatch.com
Novo Nordisk 2 may 2026 FDA Proposal Could Support Novo Nordisk GLP‑1 Exclusivity And Valuation - simplywall.st
Novo Nordisk 1 may 2026 Danish biotech firm Zealand Pharma proposes former Novo Nordisk senior to board - marketscreener.com
Novo Nordisk 1 may 2026 Novo Nordisk’s Rybelsus officially retired in US as ‘Ozempic pill’ takes branding center stage - Fierce Pharma
Novo Nordisk 1 may 2026 Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851 - Yahoo Finance
Novo Nordisk 1 may 2026 Novo Nordisk weight-loss pill sees drop in new US prescriptions - medwatch.com
Novo Nordisk 1 may 2026 A proposal seeks to remove Novo and Lilly drugs from key list in the US – will provide better protection against copies - medwatch.com
Novo Nordisk 30 abr 2026 Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO - Bloomberg.com